Johnson & Johnson Will Include Drug Prices in Television Ads
Johnson & Johnson will improve transparency regarding the cost of certain prescriptions by including pricing in television ads.
Drugs & Medical Devices
Protestors Flood Museums Partially Funded by Sacklers
Protestors flood museums the Sackler family has donated to over the years, asking them to refuse any future funding.
Beware the Potential Consequences of Using an Epidural for Pain
While an epidural seems like a better option for chronic back pain than opioids, there are risks involved, including paraylsis.
Drug Company CEOs Will Testify at Hearing Addressing Price Increases
A hearing will be held at the end of the month in which executives from top drug manufacturers will testify regarding significant price increases.
Illinois Considers Making the Switch from Opioids to Medical Marijuana
Illinois will switch some patients from opioid prescriptions to medical marijuana, which offers a safer alternative.
Doctor Suspected of Causing More Than Two Dozen Patient Deaths
Mount Carmel Hospital System physician, Dr. William Husel, is accused of prescribing high levels of pain medications that led to the deaths of 28 patients.
Government Goes After Insys Executives Using RICO
The federal government uses the Racketeer Influenced and Corrupt Organizations Act (RICO), approved in 1970, to go after Insys executives, claiming they engaged in a racketeering conspiracy scheme to realize revenues from Subsys sales.
Cancer Treatment Protocol May Change Due to Opioid Epidemic
Prescription opioids have been identified as significant contributors to the overdose epidemic. There may be a need for new alternatives for cancer treatment.
Drug Advertising is At an All-time High, According to Study
New study published in the Journal of the American Medical Association states drug advertising has skyrocketed across all mediums over the years.
Trump’s Proposal Will Make Generic Drugs More Expensive
The Trump administration is proposing changes to insurance that may increase the out-of-pocket cost of some brand-name drugs. This would mean that patients who are unwilling to opt for generics will pay more for their prescriptions.